AT1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma

E. Rivera, O. Arrieta*, P. Guevara, A. Duarte-Rojo, J. Sotelo

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

88 Scopus citations

Abstract

Malignancy of neoplasms is partly dependent on angiogenesis. Angiotensin II mediates angiogenesis and transcription of growth-related factors through stimulation of the AT1 receptor (AT1R). Losartan, a drug used mostly for treatment of hypertension, binds strongly to this receptor. We found the presence of AT1 receptor on C6 glioma cells and studied the effect of Losartan on the growth and angiogenesis of C6 rat glioma; Losartan in dose of 80 mg/kg induced 79% reduction of tumoural volume with a significant decrease of vascular density, mitotic index and cell proliferation. Our results demonstrate the conspicuous presence of AT1R in malignant glial cells and a favourable therapeutic response in experimental glioma by selective blockage of the AT1 receptor.

Original languageEnglish (US)
Pages (from-to)1396-1399
Number of pages4
JournalBritish Journal of Cancer
Volume85
Issue number9
DOIs
StatePublished - Nov 2 2001

Keywords

  • Angiogenesis
  • Angiotensin
  • Brain tumour
  • Glioma
  • Losartan

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'AT1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma'. Together they form a unique fingerprint.

Cite this